Pyrrolopyrimidines as CRF antagonists
US6765008B1 · kind B1 · utility
15Cited by
5References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 14, 1995 |
| Grant date | Jul 20, 2004 |
| Priority date | — |
| Expiry date | Jun 14, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of the formula wherein R1, R2, R3, R4, R5 and R6 are as defined herein, are useful in the treatment of stress-related and other diseases. These compounds have corticotropin-releasing factor antagonist activity and as such are of use in the treatment of stress and anxiety related, and other disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.